BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/14/2019 1:31:33 PM | Browse: 1113 | Download: 2203
 |
Received |
|
2019-04-08 00:53 |
|
Peer-Review Started |
|
2019-04-08 03:38 |
|
First Decision by Editorial Office Director |
|
2019-05-30 20:50 |
|
Return for Revision |
|
2019-05-31 02:05 |
|
Revised |
|
2019-06-20 13:22 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2019-07-01 09:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2019-07-03 01:10 |
|
Articles in Press |
|
2019-07-03 01:10 |
|
Edit the Manuscript by Language Editor |
|
2019-07-15 21:43 |
|
Typeset the Manuscript |
|
2019-08-07 06:42 |
|
Publish the Manuscript Online |
|
2019-08-14 13:31 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Francesco Baratta, Daniele Pastori, Domenico Ferro, Giovanna Carluccio, Giulia Tozzi, Francesco Angelico, Francesco Violi and Maria Del Ben |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Francesco Angelico, MD, Associate Professor, Professor, Department of Public Health and Infectious Diseases, Sapienza University, viale del Policlinico 155, Rome 00161, Italy. francesco.angelico@uniroma1.it |
| Key Words |
Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Lysosomal acid lipase; Cirrhosis; Wolman disease; Cholesterol ester storage disease |
| Core Tip |
Reduced lysosomal acid lipase (LAL) activity promotes an increased multi-organ lysosomal cholesterol esters storage, as observed in two recessive autosomal genetic diseases, Wolman disease and Cholesterol ester storage disease. A less severe and non-genetic reduction of LAL activity has been reported in children and adults with non-alcoholic fatty liver disease (NAFLD). Patients with NAFLD show a significant, progressive reduction of LAL activity from simple steatosis, to non-alcoholic steatohepatitis and cryptogenic cirrhosis. In the future, modulation of LAL activity may become a possible new therapeutic target for patients with more advanced forms of NAFLD and represent a possible new marker of disease severity. |
| Publish Date |
2019-08-14 13:31 |
| Citation |
Francesco B, Daniele P, Domenico F, Giovanna C, Giulia T, Francesco A, Francesco V, Maria DB. Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease? World J Gastroenterol 2019; 25(30): 4172-4180 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i30/4172.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i30.4172 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
